Imiquimod
- 1 trial
- Animals3
Trial sponsors
1 trialPhase 1119 people
Latest
1 in 12 monthsApplied Biochemistry and Biotechnology
Basal Medium Affects the Biological Characteristics and Immunomodulatory Functions of MSCs
Experiments in miceInterventions
Stem Cell Research & Therapy
Overexpression of SOX4 in MSCs inhibits cellular senescence and enhances therapeutic efficacy in systemic lupus erythematosus
Experiments in miceSystemic lupus erythematosus
Frontiers in Nutrition
Caloric restriction impacts skin barrier function and attenuates the development of hyperplasia skin disease
Experiments in miceDietary restriction
International Journal of Molecular Sciences
Uncovering the Molecular Pathways Implicated in the Anti-Cancer Activity of the Imidazoquinoxaline Derivative EAPB02303 Using a Caenorhabditis elegans Model
Experiments in wormsInterventions
Journal of Dermatological Science
Topical application of a BCL-2 inhibitor ameliorates imiquimod-induced psoriasiform dermatitis by eliminating senescent cells
Experiments in micePsoriasis
MedComm
Metabolic shifts during coffee consumption refresh the immune response: insight from comprehensive multiomics analysis
Cross-sectional study in peopleCoffee
Archives of Dermatological Research
Intermittent fasting alleviates IMQ-induced psoriasis-like dermatitis via reduced γδT17 and monocytes in mice
Experiments in miceIntermittent fasting
Antioxidants
The Role of Nicotinamide Mononucleotide Supplementation in Psoriasis Treatment
Experiments in miceNicotinamide mononucleotide